177 related articles for article (PubMed ID: 35549533)
1. Unusual presentation of rare
Gupta R; Lin M; Bokhari S
Future Cardiol; 2022 Jun; 18(6):471-476. PubMed ID: 35549533
[TBL] [Abstract][Full Text] [Related]
2. Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant.
Ikura H; Kitakata H; Endo J; Moriyama H; Sano M; Tsujikawa H; Sawano M; Masuda T; Ohki T; Ueda M; Kosaki K; Fukuda K
Eur J Med Genet; 2022 Mar; 65(3):104451. PubMed ID: 35149236
[TBL] [Abstract][Full Text] [Related]
3. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
[TBL] [Abstract][Full Text] [Related]
4. First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant.
Lyng CS; Gude E; Hodt A; Knudsen EC
Scand Cardiovasc J; 2023 Dec; 57(1):2174269. PubMed ID: 36734834
[TBL] [Abstract][Full Text] [Related]
5. Hereditary transthyretin amyloidosis overview.
Manganelli F; Fabrizi GM; Luigetti M; Mandich P; Mazzeo A; Pareyson D
Neurol Sci; 2022 Dec; 43(Suppl 2):595-604. PubMed ID: 33188616
[TBL] [Abstract][Full Text] [Related]
6. Transthyretin Variant Amyloidosis with a TTR A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy.
Ikeda K; Yamamoto D; Usui K; Takeuchi H; Oka N; Katoh N; Yazaki M; Kametani F; Nishino I; Hisahara S
Intern Med; 2023 Aug; 62(15):2261-2266. PubMed ID: 36543209
[TBL] [Abstract][Full Text] [Related]
7. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.
Carroll A; Dyck PJ; de Carvalho M; Kennerson M; Reilly MM; Kiernan MC; Vucic S
J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):668-678. PubMed ID: 35256455
[TBL] [Abstract][Full Text] [Related]
9. A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report.
Thimm A; Oubari S; Hoffmann J; Carpinteiro A; Papathanasiou M; Luedike P; Kessler L; Rischpler C; Röcken C; Diebold I; Rassaf T; Schmidt H; Kleinschnitz C; Hagenacker T
BMC Neurol; 2022 Dec; 22(1):469. PubMed ID: 36494773
[TBL] [Abstract][Full Text] [Related]
10. Hereditary transthyretin amyloidosis caused by the rare Phe33Leu mutation.
Björkenheim A; Szabó B; Sztaniszláv ÁJ
BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31932463
[TBL] [Abstract][Full Text] [Related]
11. The neuropathy in hereditary transthyretin amyloidosis: A narrative review.
Tozza S; Severi D; Spina E; Iovino A; Aruta F; Ruggiero L; Dubbioso R; Iodice R; Nolano M; Manganelli F
J Peripher Nerv Syst; 2021 Jun; 26(2):155-159. PubMed ID: 33960565
[TBL] [Abstract][Full Text] [Related]
12. Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid.
Tsai FJ; Jaeger M; Coelho T; Powers ET; Kelly JW
Amyloid; 2023 Sep; 30(3):279-289. PubMed ID: 36691999
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive detection and differentiation of cardiac amyloidosis using
Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
15. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
[TBL] [Abstract][Full Text] [Related]
16. Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis.
Salvi F; Volpe R; Pastorelli F; Bianchi A; Vella A; Rapezzi C; Mascalchi M
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e212-e214. PubMed ID: 29779881
[TBL] [Abstract][Full Text] [Related]
17. Neuropathology of central nervous system involvement in TTR amyloidosis.
Taipa R; Sousa L; Pinto M; Reis I; Rodrigues A; Oliveira P; Melo-Pires M; Coelho T
Acta Neuropathol; 2023 Jan; 145(1):113-126. PubMed ID: 36198883
[TBL] [Abstract][Full Text] [Related]
18. Deterioration after Liver Transplantation and Transthyretin Stabilizer Administration in a Patient with ATTRv Amyloidosis with a Leu58Arg (p.Leu78Arg) TTR Variant.
Hikishima S; Sakai K; Akagi A; Yamaguchi H; Shibata S; Hayashi K; Nakano H; Kanemoto M; Usui Y; Taniguchi Y; Komatsu J; Nakamura-Shindo K; Nozaki I; Hamaguchi T; Ono K; Iwasa K; Yamada M
Intern Med; 2022 Aug; 61(15):2347-2351. PubMed ID: 35283385
[TBL] [Abstract][Full Text] [Related]
19. Hereditary Transthyretin Amyloidosis in Eight Chinese Families.
Meng LC; Lyu H; Zhang W; Liu J; Wang ZX; Yuan Y
Chin Med J (Engl); 2015 Nov; 128(21):2902-5. PubMed ID: 26521788
[TBL] [Abstract][Full Text] [Related]
20. Rare c.302C>T
Žebrauskienė D; Sadauskienė E; Masiulienė R; Aidietienė S; Šiaudinienė A; Pečeliūnas V; Žukauskaitė G; Žurauskas E; Valevičienė N; Barysienė J; Preikšaitienė E
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
